WIPO trademark

ABLIXELA

RegisteredWIPOClass 5

"ABLIXELA" is a trademark owned by Biofarma, filed at the WIPO on May 26, 2026. It is registered and covers class 5 (Pharmaceuticals).

ABLIXELA
Trademark as filed with the WIPO
Status
Registered
Since June 22, 2026
Filed
May 26, 2026
Registered
Not yet
Expires
May 26, 2036
Application no.
Not recorded
Registration no.
1926567
Office
WIPO
World Intellectual Property Organization
Mark type
Trademark
1 class
Ownership

Who owns ABLIXELA

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services ABLIXELA is filed for, grouped by Nice class.

  • Pharmaceutical products for cardiovascular disease prevention and treatment; pharmaceutical products for metabolic system disease prevention and treatment.

FAQ

About ABLIXELA

Who owns the trademark "ABLIXELA"?

The WIPO trademark "ABLIXELA" is owned by Biofarma.

What is the status of "ABLIXELA"?

Its status at the WIPO is: registered.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull ABLIXELA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_b9084d6b-ac21-4452-98e2-a49ed1a94a5d
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_b9084d6b-ac21-4452-98e2-a49ed1a94a5d",
  "object": "trademark",
  "mark_text": "ABLIXELA",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "WO",
  "application_number": null,
  "filing_date": "2026-05-26",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "BIOFARMA",
      "entity_id": "ent_019eb7a4-801f-7200-9074-3a8d4e459b8b"
    }
  ]
}